CRO Adds Leadership Team Member at Bioanalytical Center of Excellence; Continues to Meet and Exceed Growing Marketplace Demand for Comprehensive Bioanalytical Services
November 29, 2023 08:00 AM Eastern Standard Time
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Worldwide Clinical Trials (Worldwide), a leading global, full-service contract research organization (CRO), has appointed Jayaprakash (JP) Kotha, MBBS, Ph.D, ASCP (SH), as Vice President, Bioanalytical. Kotha now leads lab operations and all activities in Worldwide’s Bioanalytical Center of Excellence, located in Austin, Texas.
“Worldwide is known for its specialized approach to bioanalytical services and clinical trials – one that prioritizes personalized partnerships and accessible technical expertise for its customers. I look forward to contributing greatly to the business.”Post this
The Bioanalytical Lab at Worldwide continues to grow with the industry to provide customers with small and large molecule bioanalysis, PK/PD analysis, and genotyping expertise. In 2022, the company opened the Bioanalytical Center of Excellence, a state-of-the-art, 60,000 square foot facility outfitted with a full automation suite, modern infrastructure, and efficient, fit-for-purpose lab space to flexibly support current and future research demands while enabling optimized workflows to ensure critical customer timelines are met. The Bioanalytical Center of Excellence is also set up to meet and exceed the increasing demand within the large molecule bioanalytical testing services market with an additional 15,000 square foot lab dedicated to large molecule.
“JP’s extensive scientific background makes him the perfect fit to lead our Bioanalytical laboratory, particularly at a time when we are growing our service offerings to best meet the needs of our customers,” said Mike Mencer, Executive Vice President and General Manager, Early Phase. “I am confident that JP’s leadership will drive further success that helps our customers improve the lives of patients by bringing new drugs and treatments to market.”
“It is exciting to join the Worldwide Clinical Trials team, especially during a time of such transformation and progress,” said Kotha. “Worldwide is known for its specialized approach to bioanalytical services and clinical trials – one that prioritizes personalized partnerships and accessible technical expertise for its customers. I look forward to contributing greatly to the business.”
As a scientist with more than 25 years of diagnostic and research laboratory experience in cardiovascular, hematology, oncology, and immunology, Kotha is well versed in leading cross-functional teams engaged in clinical and translational research for the development of biologics and small-molecule therapeutics. He offers extensive experience in development and validation of bioanalytical assays for pharmacodynamic, pharmacokinetic, biomarker, and immunogenicity testing for novel therapeutics on diverse technological platforms and in guiding research scientists and project managers engaged in laboratory testing for clinical research.
To learn more about Worldwide’s bioanalytical services, click here.
About Worldwide Clinical Trials:
Worldwide Clinical Trials (Worldwide) is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new medications – from discovery to reality. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our accessible team of clinicians, scientists, and researchers who bring first-hand expertise and a collaborative, personalized approach to each clinical program.
Anchored in our company’s scientific heritage, we are therapeutically focused on neuroscience, oncology, rare diseases, and cardiometabolic disorders. Our deep therapeutic knowledge and country-specific operational acumen enable us to develop flexible plans and quickly solve problems for our customers.
Our team of 3,300+ professionals spans 60+ countries, and believes that through a culture that embraces diversity, equity, inclusion, and belonging (DEI&B), everyone plays a vital role in making a world of difference for patients and their caregivers. We are united in cause with our customers to improve the lives of patients through new, innovative therapies.
For more information on Worldwide, visit www.Worldwide.com or connect with us on LinkedIn.
Contacts
Jill Mastrangelo
[email protected]
Discover more from Impact Newswire
Subscribe to get the latest posts sent to your email.
